Search
for
Sort by
Research 571–600 of 1000+
- SUMMARIES OF PAPERS
- Characteristics of finasteride users in comparison with nonusers: A Nordic nationwide study based on individual‐level data from Denmark, Finland, and Sweden
- Rare clinical features of the Ellis van Creveld syndrome: A case report and literature review
- Prophylaxis and Management of Skin Toxicities
- Oral minoxidil for late alopecia in cancer survivors
- RANK as a therapeutic target in cancer
- Finasteride-Induced Gynecomastia in a 62-Year-Old Man
- Giant Morpheaform Basal Cell Carcinoma Mimicking Scarring Alopecia: Exception Prone to Neglect
- 1421 Primary cutaneous diffuse large B-cell lymphoma–leg type masquerading as a mucocele
- Madarosis and facial keratinaceous spines
- In vitro cytotoxicity of selenium on a human mammary tumor cell line: and the effect of dietary selenium and magnesium on tumor growth in vivo
- Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.
- Monitoring chemotherapy‐induced alopecia with trichoscopy
- Eyelash Preservation During Chemotherapy and Topical Prostaglandin Therapy
- 5116 Postmenopausal Hyperandrogenism due to Rare Ovarian Tumor
- 9243 Postmenopausal Hyperandrogenism due to Rare Ovarian Tumor
- 9243 Postmenopausal Hyperandrogenism due to Rare Ovarian Tumor
- NEW ENGLAND DERMATOLOGICAL SOCIETY
- Vitamin E TPGS based transferosomes augmented TAT as a promising delivery system for improved transdermal delivery of raloxifene
- Scalp cooling in the prevention of anthracycline-induced alopecia
- 18F-FDG PET Uptake in the Scalp After Platelet-Rich Plasma Therapy
- A phase I safety study of topical calcitriol (BPM 31543) for the prevention of chemotherapy-induced alopecia (CIA).
- 269 Scalp cooling for chemotherapy-induced alopecia in skin of color patients: An interventional study
- Persistent Gynecomastia due to Short-term Low-dose Finasteride for Androgenetic Alopecia
- A Case of Gynecomastia Induced by Use of Doxazosin
- Case Study: Hereditary Cancer Genetic Testing in Unaffected Patients May Allow for Early Intervention and Aggressive Management
- Putting it all together: How do primary care physicians interpret and use the results of prevention trials?
- Questions and Answers
- Docetaxel.
- 2-Substituted 4-(Thio)chromenone 6-<i>O</i>-Sulfamates: Potent Inhibitors of Human Steroid Sulfatase